Study Evaluating Safety and Efficacy of Bimiralisib in Patients With Head and Neck Squameous Cell Carcinoma

Condition:   HNSCC
Intervention:   Drug: Bimiralisib
Sponsor:   PIQUR Therapeutics AG
Not yet recruiting

https://ift.tt/2K2G78h